Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

154.68
-3.2600-2.06%
Post-market: 154.680.00000.00%18:58 EDT
Volume:289.07K
Turnover:44.80M
Market Cap:9.26B
PE:-22.88
High:158.55
Open:157.94
Low:154.00
Close:157.94
Loading ...
Oct 08, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 08, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 03, 2020

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 01, 2020

important event

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 31, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 12, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 05, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 15, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 13, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]